Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin in advanced chronic kidney disease
NCT03325322Phase 2Suspended
- Sponsor
- Mayo Clinic
- Start
- Jan 2018
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in chronic kidney disease (CKD), diabetic nephropathy (DN), sponsored by Mayo Clinic. Started Jan 2018; status: suspended.
02
Drugs
fisetin
03
Conditions
chronic kidney disease (CKD)diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03325322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325322.